Marvel Biosciences Financials
| MRVL Stock | 0.17 0.01 6.25% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.53 | 0.56 |
|
|
Marvel | Select Account or Indicator |
Understanding current and past Marvel Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Marvel Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Marvel Biosciences' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Marvel Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Marvel Biosciences Corp. Check Marvel Biosciences' Beneish M Score to see the likelihood of Marvel Biosciences' management manipulating its earnings.
Marvel Biosciences Stock Summary
Marvel Biosciences competes with XORTX Therapeutics, and Innovotech. Marvel Biosciences is entity of Canada. It is traded as Stock on V exchange.| Foreign Associate | USA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | Canada Stock View All |
| Exchange | TSX Venture Exchange |
| ISIN | CA57384M1077 |
| Business Address | 505 8th Avenue |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | marvelbiotechnology.com |
| Phone | 403 770 2469 |
You should never invest in Marvel Biosciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Marvel Stock, because this is throwing your money away. Analyzing the key information contained in Marvel Biosciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Marvel Biosciences Key Financial Ratios
There are many critical financial ratios that Marvel Biosciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Marvel Biosciences Corp reports annually and quarterly.| Return On Equity | -3.8 | ||||
| EBITDA | (2.19 M) | ||||
| Net Income | (2.29 M) | ||||
| Book Value Per Share | (0.07) X | ||||
| Market Capitalization | 7.39 M |
Marvel Biosciences Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Retained Earnings | (1.2M) | (4.2M) | (6.8M) | (9.0M) | (8.1M) | (7.7M) | |
| Accounts Payable | 94.2K | 1.6K | 262.1K | 1.2M | 1.4M | 1.5M | |
| Total Current Assets | 295.7K | 2.5M | 913.5K | 672.4K | 773.2K | 956.9K |
Marvel Biosciences Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 224.6K | 2.2M | (1.8M) | (36.6K) | (32.9K) | (31.3K) | |
| Total Cash From Operating Activities | (538.5K) | (1.4M) | (2.2M) | (1.3M) | (1.2M) | (1.3M) | |
| Net Income | (955.7K) | (3.0M) | (2.6M) | (2.3M) | (2.1M) | (2.2M) | |
| Total Cash From Financing Activities | 763.2K | 3.2M | 394K | 1.3M | 1.5M | 1.3M | |
| End Period Cash Flow | 224.8K | 2.4M | 593.2K | 556.6K | 640.1K | 829.0K |
Marvel Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Marvel Biosciences's current stock value. Our valuation model uses many indicators to compare Marvel Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Marvel Biosciences competition to find correlations between indicators driving Marvel Biosciences's intrinsic value. More Info.Marvel Biosciences Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Marvel Biosciences' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Marvel Biosciences' earnings, one of the primary drivers of an investment's value.Marvel Biosciences Corp Systematic Risk
Marvel Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Marvel Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Marvel Biosciences Corp correlated with the market. If Beta is less than 0 Marvel Biosciences generally moves in the opposite direction as compared to the market. If Marvel Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Marvel Biosciences Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Marvel Biosciences is generally in the same direction as the market. If Beta > 1 Marvel Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
Marvel Biosciences Corp Total Current Liabilities Over Time
Today, most investors in Marvel Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Marvel Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Marvel Biosciences growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Marvel Biosciences November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Marvel Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Marvel Biosciences Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Marvel Biosciences Corp based on widely used predictive technical indicators. In general, we focus on analyzing Marvel Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Marvel Biosciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 12.53 | |||
| Information Ratio | 0.0909 | |||
| Maximum Drawdown | 48.57 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 14.29 |
Additional Tools for Marvel Stock Analysis
When running Marvel Biosciences' price analysis, check to measure Marvel Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marvel Biosciences is operating at the current time. Most of Marvel Biosciences' value examination focuses on studying past and present price action to predict the probability of Marvel Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marvel Biosciences' price. Additionally, you may evaluate how the addition of Marvel Biosciences to your portfolios can decrease your overall portfolio volatility.